- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06375720
Efficacy of Different Doses of Tai Chi Chuan on Cognitive Function in Persons With Mild Cognitive Impairment
April 16, 2024 updated by: Lidian Chen
Dose-effect of Different Frequencies and Duration of Tai Chi Chuan to Improve Cognitive Function in Persons With Mild Cognitive Impairment
To determine the relationship between the effects of different frequencies and duration of Tai Chi Chuan in dose parameters to improve cognitive function in elderly persons with mild cognitive impairment.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
Mild cognitive impairment (MCI) is regarded as a prodrome to dementia and affects 16% to 20% of people aged older than 65 years.
Tai Chi Chuan is an increasingly popular multi-modal physical and mental exercise.
Studies have shown that Tai Chi Chuan can effectively improve the cognitive function of elderly persons with MCI.
However, the relationship between the effects of different frequencies and duration of Tai Chi Chuan to improve the cognitive function of elderly persons with MCI is not yet clear.
The purpose of this study is to determine the optimal frequency and duration of Tai Chi Chuan.
The investigators will conduct a single-blind, randomized controlled trial in 350 persons who meet the presence of MCI without dementia.
Persons will be randomly assigned to either the Tai Chi Chuan intervention group once or twice a week for 12 or 24 weeks, or the health education control group once every four weeks for 24 weeks.
All groups will be followed for 52 weeks.
Study Type
Interventional
Enrollment (Estimated)
350
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Presence of mild cognitive impairment, not demented;
- Age ≥ 60 years old;
- Informed consent and voluntary participation.
Exclusion Criteria:
- Geriatric Depression Scale score ≥ 9 points;
- Cognitive impairment caused by other reasons, taking drugs, poisoning, etc;
- Suffer from severe musculoskeletal system diseases and other contraindications to exercise and are not suitable for Tai Chi Chuan training, such as those who suffer from stroke, Parkinson's disease, and have a history of lower limb arthritis, hip and knee joint replacement, etc;
- Patients with severe heart, liver, kidney failure, malignant tumors, and other major diseases;
- Individuals with visual/auditory impairments, writing/reading impairments, illiteracy, etc. that affect training and evaluation;
- Individuals with uncontrolled hypertension (systolic blood pressure greater than 160mmHg or diastolic blood pressure greater than 100mmHg after medication);
- Participating in other experiments that influence this study;
- Engaged in regular exercise in the last three months (at least 3 times a week, at least 20 minutes of regular exercise each time).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Tai Chi Chuan Group1
12 weeks of Tai Chi Chuan, 3x/week
|
Participants would take 24-form simplified Tai Chi Chuan 1 hour/session, 3 sessions/week for 12 weeks.
There were 10 minutes warm-up, 40 minutes Tai Chi Chuan lesson and 10 minutes cool-down exercises in the Tai Chi Chuan training.
Besides, they would also take standard health education 0.5 hour/session, 2 sessions/month for 6 months.
|
|
Experimental: Tai Chi Chuan Group2
12 weeks of Tai Chi Chuan, 5x/week
|
Participants would take 24-form simplified Tai Chi Chuan 1 hour/session, 5 sessions/week for 12 weeks.
There were 10 minutes warm-up, 40 minutes Tai Chi Chuan lesson and 10 minutes cool-down exercises in the Tai Chi Chuan training.
Besides, they would also take standard health education 0.5 hour/session, 2 sessions/month for 6 months.
|
|
Experimental: Tai Chi Chuan Group3
24 weeks of Tai Chi Chuan, 3x/week
|
Participants would take 24-form simplified Tai Chi Chuan 1 hour/session, 3 sessions/week for 24 weeks.
There were 10 minutes warm-up, 40 minutes Tai Chi Chuan lesson and 10 minutes cool-down exercises in the Tai Chi Chuan training.
Besides, they would also take standard health education 0.5 hour/session, 2 sessions/month for 6 months.
|
|
Experimental: Tai Chi Chuan Group4
24 weeks of Tai Chi Chuan, 5x/week
|
Participants would take 24-form simplified Tai Chi Chuan 1 hour/session, 5 sessions/week for 24 weeks.
There were 10 minutes warm-up, 40 minutes Tai Chi Chuan lesson and 10 minutes cool-down exercises in the Tai Chi Chuan training.
Besides, they would also take standard health education 0.5 hour/session, 2 sessions/month for 6 months.
|
|
Sham Comparator: Control
Participants would take standard health education 0.5hour/ session, 2 sessions/month for 6 months.
|
Participants would take standard health education 0.5 hour/ session, 2 sessions/month for 6 months.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Montreal Cognitive Assessment
Time Frame: 12 weeks, 24 weeks
|
Global cognition
|
12 weeks, 24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Montreal Cognitive Assessment
Time Frame: 52 weeks
|
Global cognition
|
52 weeks
|
|
Wechsler Memory Scale
Time Frame: 12 weeks, 24 weeks and 52 weeks
|
Memory function
|
12 weeks, 24 weeks and 52 weeks
|
|
Digit Symbol Substitution Test
Time Frame: 12 weeks, 24 weeks and 52 weeks
|
Attention
|
12 weeks, 24 weeks and 52 weeks
|
|
Trial Making Test part B
Time Frame: 12 weeks, 24 weeks and 52 weeks
|
Executive Function
|
12 weeks, 24 weeks and 52 weeks
|
|
Stroop Color Word Test
Time Frame: 12 weeks, 24 weeks and 52 weeks
|
Processing Speed
|
12 weeks, 24 weeks and 52 weeks
|
|
Boston Naming Test
Time Frame: 12 weeks, 24 weeks and 52 weeks
|
Verbal fluency
|
12 weeks, 24 weeks and 52 weeks
|
|
Rey-Osterrieth Complex Graphics Test
Time Frame: 12 weeks, 24 weeks and 52 weeks
|
Visuo-spatial ability
|
12 weeks, 24 weeks and 52 weeks
|
|
Rey Auditory Verbal Learning Test
Time Frame: 12 weeks, 24 weeks and 52 weeks
|
Episodic memory
|
12 weeks, 24 weeks and 52 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Pittsburgh Sleep Quality Index (PSQI)
Time Frame: 12 weeks, 24 weeks and 52 weeks
|
Sleep quality
|
12 weeks, 24 weeks and 52 weeks
|
|
12-Item Short Form Health Survey
Time Frame: 12 weeks, 24 weeks and 52 weeks
|
General health
|
12 weeks, 24 weeks and 52 weeks
|
|
Blood glucose metabolism index
Time Frame: 12 weeks, 24 weeks and 52 weeks
|
fasting blood glucose
|
12 weeks, 24 weeks and 52 weeks
|
|
Blood lipid metabolism index
Time Frame: 12 weeks, 24 weeks and 52 weeks
|
total cholesterol (TC); total triglyceride (TG); low density lipoprotein (LDL);high density lipoprotein (HDL)
|
12 weeks, 24 weeks and 52 weeks
|
|
functional Magnetic Resonance Imaging
Time Frame: 12 weeks or 24 weeks [post-intervention]
|
functional Magnetic Resonance Imaging
|
12 weeks or 24 weeks [post-intervention]
|
|
Electroencephalogram
Time Frame: 12 weeks or 24 weeks [post-intervention]
|
The power spectrum density of the brain in a relaxed state is measured using a resting-state electroencephalogram (EEG) for the delta (1-4 Hz), theta (4-8 Hz), alpha (8-13 Hz), beta (13-30 Hz), and gamma (30-100 Hz) bands.
|
12 weeks or 24 weeks [post-intervention]
|
|
Heart rate variability
Time Frame: 12 weeks or 24 weeks [post-intervention]
|
Cardiac autonomic modulations
|
12 weeks or 24 weeks [post-intervention]
|
|
Gut microflora
Time Frame: 12 weeks, 24 weeks and 52 weeks
|
16S rRNA amplification sequencing was used to detect intestinal microbiota.
|
12 weeks, 24 weeks and 52 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
May 5, 2024
Primary Completion (Estimated)
June 15, 2025
Study Completion (Estimated)
December 15, 2025
Study Registration Dates
First Submitted
March 21, 2024
First Submitted That Met QC Criteria
April 16, 2024
First Posted (Actual)
April 19, 2024
Study Record Updates
Last Update Posted (Actual)
April 19, 2024
Last Update Submitted That Met QC Criteria
April 16, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- FujianUTCM-2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mild Cognitive Impairment
-
Saglik Bilimleri UniversitesiAnkara UniversityRecruitingAmnestic Mild Cognitive Impairment | Amnestic Mild Cognitive DisorderTurkey
-
Masaryk UniversityRecruitingMild Cognitive Impairment (MCI) Amnestic | Lewy Body Disease With Mild Cognitive Impairment | Parkinson's Disease With Mild Cognitive ImpairmentCzechia
-
BaycrestCentre for Aging and Brain Health InnovationUnknownNeurocognitive Disorders | Cognitive Dysfunction | Mental Disorder | Cognitive Impairment, Mild | Cognitive Disorder | Nonamnestic Mild Cognitive ImpairmentCanada
-
Singapore General HospitalSingapore Health ServicesNot yet recruitingMild Cognitive Impairment (MCI) | Mild Cognitive Impairment
-
Xuanwu Hospital, BeijingNot yet recruitingMild Cognitive Impairment (MCI)China
-
The Hong Kong Polytechnic UniversityJohns Hopkins University; The University of Hong Kong; University of ReadingNot yet recruitingMild Cognitive Impairment (MCI)Hong Kong
-
Universidad Complutense de MadridAB Biotics, SANot yet recruitingMild Cognitive Impairment (MCI)Spain
-
University of SheffieldNot yet recruitingMild Cognitive Impairment (MCI)United Kingdom
-
The Hong Kong Polytechnic UniversityRecruitingMild Cognitive Impairment (MCI)Hong Kong
-
Mackay Memorial HospitalBened Biomedical Co., Ltd.TerminatedMild Cognitive Impairment (MCI)Taiwan
Clinical Trials on Lower frequency, shorter period of Tai Chi Chuan
-
Tufts Medical CenterNational Center for Complementary and Integrative Health (NCCIH)Completed
-
Aswan University HospitalCompletedCesarean Section ComplicationsEgypt